The neuropeptide in ischemic brain injury: insights, challenges, and horizon of targeted interventions.

Stroke is one of the leading causes of death and disability worldwide, and researchers are working hard to find better treatments. A new scientific review published in the Journal of Translational Medicine explores how the brain's own natural chemical messengers — called neuropeptides — play a role in what happens during and after a stroke.

Neuropeptides are small proteins your brain and nervous system produce naturally. You may have heard of some of them, like oxytocin (the "bonding hormone") or substance P (involved in pain signaling). This review looked at ten different neuropeptides and how they behave during the four stages of ischemic stroke — from the first moments of a blocked blood vessel all the way through long-term recovery.

What scientists found is remarkable: these neuropeptides aren't passive bystanders. They actively influence whether brain cells survive or die, how much inflammation occurs, and how well the brain recovers over time. Some neuropeptides appear protective, while others can worsen damage depending on the stage of stroke.

So what does this mean for acupuncture patients? Research has long suggested that acupuncture stimulates the release of the body's own neuropeptides, including endorphins, CGRP, and substance P. This review strengthens the scientific rationale for why acupuncture may support stroke recovery — by naturally encouraging the brain's own healing chemistry at the right time and in the right places. While acupuncture is not a replacement for emergency stroke care, it is increasingly recognized as a valuable part of post-stroke rehabilitation, helping with movement, pain, and neurological recovery.

If you or a loved one is navigating stroke recovery, speak with a licensed acupuncturist who has experience in neurological rehabilitation to explore whether acupuncture may be a helpful addition to your care plan.

This systematic review in the Journal of Translational Medicine examines the stage-dependent roles of ten endogenous neuropeptides — opioid peptides, oxytocin, orexin, PACAP, CGRP, CART peptide, substance P, galanin, neuropeptide Y (NPY), and vasopressin — across the hyperacute, acute, subacute, and chronic phases of cerebral ischemic stroke (CIS). No specific sample size applies given the systematic review design; effect sizes were not pooled quantitatively. Key findings indicate that neuropeptides exert phase-specific regulatory effects on neuroprotection, neuroinflammation, excitotoxicity, and neural repair. Several, including CGRP and opioid peptides, demonstrate neuroprotective profiles relevant to acupuncture's known mechanism of endogenous neuropeptide modulation. Clinical takeaway: acupuncture's capacity to upregulate endogenous neuropeptide release positions it as a mechanistically plausible adjunct in post-stroke rehabilitation. Future pharmacological work focuses on receptor subtype-specific agents and novel CNS delivery systems — insights that parallel discussions around optimizing acupuncture point selection and stimulation parameters for neurorecovery protocols.